Amar Murugan
SVP, GC & Secretary, Atara Biotherapeutics, Inc.
Companies
- ACELYRIN, Inc.General counsel Nov 22, 2024 to now1
- Atara Biotherapeutics, Inc.General counsel May 18, 2023 to Aug 20, 20242
- Atara Biotherapeutics, Inc.SVP, GC & Secretary Apr 21, 2020 to Mar 6, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Atara Biotherapeutics, Inc. ATRA26,827 shares4$247.9K at $9.24Aug 16, 2024
- ACELYRIN, Inc.0 shares5May 21, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- May 21, 2025Returned to company 121,587 shares of ACELYRIN, Inc.5
- Mar 17, 2025Sold 3,913 shares at $2.74 of ACELYRIN, Inc.6
- Jan 23, 2025Granted 125,000 shares of ACELYRIN, Inc.7
- Aug 16, 2024Sold 89 shares at $6.63 of Atara Biotherapeutics, Inc.4
- Aug 16, 2024Sold 192 shares at $6.63 of Atara Biotherapeutics, Inc.4
- Aug 16, 2024Sold 877 shares at $6.63 of Atara Biotherapeutics, Inc.4
- May 16, 2024Sold 32,401 shares at $0.62 of Atara Biotherapeutics, Inc.8
- Mar 4, 2024Sold 10,044 shares at $0.72 of Atara Biotherapeutics, Inc.9
- Jan 8, 2024Granted 475,000 shares of Atara Biotherapeutics, Inc.10
- Nov 16, 2023Sold 8,307 shares at $0.39 of Atara Biotherapeutics, Inc.11
- Aug 16, 2023Sold 3,622 shares at $1.65 of Atara Biotherapeutics, Inc.12
- Aug 16, 2023Sold 5,050 shares at $1.65 of Atara Biotherapeutics, Inc.12
- May 16, 2023Sold 985 shares at $2.04 of Atara Biotherapeutics, Inc.13
- May 16, 2023Sold 7,404 shares at $2.04 of Atara Biotherapeutics, Inc.13
- Mar 2, 2023Sold 4,221 shares at $3.63 of Atara Biotherapeutics, Inc.14
- Mar 1, 2023Granted 155,375 shares of Atara Biotherapeutics, Inc.15
- Nov 16, 2022Sold 3,612 shares at $4.49 of Atara Biotherapeutics, Inc.16
- Aug 16, 2022Sold 2,234 shares at $5.04 of Atara Biotherapeutics, Inc.17
- Aug 16, 2022Sold 1,196 shares at $5.03 of Atara Biotherapeutics, Inc.17
- May 17, 2022Sold 906 shares at $5.32 of Atara Biotherapeutics, Inc.18
- May 17, 2022Sold 2,317 shares at $5.32 of Atara Biotherapeutics, Inc.18
- Mar 1, 2022Sold 1,112 shares at $9.86 of Atara Biotherapeutics, Inc.19
- Mar 1, 2022Sold 1,465 shares at $9.86 of Atara Biotherapeutics, Inc.19
- Mar 1, 2022Granted 51,814 shares of Atara Biotherapeutics, Inc.19
- Nov 16, 2021Sold 2,124 shares at $17.12 of Atara Biotherapeutics, Inc.20
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARACELYRIN, Inc., General counsel
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 19, 2025
- 7SEC EDGARForm 4 filed Jan 24, 2025
- 8SEC EDGARForm 4 filed May 20, 2024
- 9SEC EDGARForm 4 filed Mar 6, 2024
- 10SEC EDGARForm 4 filed Jan 9, 2024
- 11SEC EDGARForm 4 filed Nov 20, 2023
- 12SEC EDGARForm 4 filed Aug 18, 2023
- 13SEC EDGARForm 4 filed May 18, 2023
- 14SEC EDGARForm 4 filed Mar 6, 2023
- 15SEC EDGARForm 4 filed Mar 3, 2023
- 16SEC EDGARForm 4 filed Nov 18, 2022
- 17SEC EDGARForm 4 filed Aug 18, 2022
- 18SEC EDGARForm 4 filed May 19, 2022
- 19SEC EDGARForm 4 filed Mar 3, 2022
- 20SEC EDGARForm 4 filed Nov 18, 2021